FDA Expected To Approve Esketamine Nasal Spray For Depression By Jon Hamilton Published March 4, 2019 at 4:41 PM PST Facebook Email Listen • 3:31 The Food and Drug Administration is expected to approve a new type of drug for depression. It is esketamine, a chemical cousin of the anesthetic and party drug ketamine. Copyright 2024 NPR